A hidden brain shift between ages 50 and 75 may explain Alzheimer’s risk

Researchers at the New York Genome Center have found that the human hippocampus undergoes a sharp, previously undocumented immune cell turnover somewhere between ages 50 and 75, with protective microglia that trace back to embryonic development giving way to blood-derived replacements carrying a stronger inflammatory signature. The finding, published in the journal Science, offers one of the clearest molecular explanations yet for why growing older is the single biggest known risk factor for Alzheimer’s disease. It emerged from single-cell sequencing of donated human brain tissue rather than mouse models, one reason the team views the shift as directly relevant to midlife brain health.

A cell handoff inside the aging hippocampus

Microglia are the brain’s resident immune cells, and most of them are seeded before birth, then expected to persist for a lifetime doing routine cleanup: clearing debris, pruning unused connections, keeping inflammation in check. The new analysis found that this embryonic population does not simply age in place inside the hippocampus, the brain region central to memory formation. Between the ages of 50 and 75, researchers documented a marked decline in these original cells and their replacement by microglia bearing molecular signatures closer to blood-derived immune cells.

Bing Ren, scientific director and CEO of the New York Genome Center and a professor at Columbia University, led the analysis and described the stakes of that handoff bluntly in the center’s own announcement of the findings: “Microglia are critical for maintaining brain homeostasis. When these cells fail to perform their housekeeping duties, toxic materials accumulate that can trigger inflammatory processes that may contribute to neurodegenerative diseases.”

The replacement cells are not simply older versions of the originals. They carry gene-expression patterns that push toward inflammation rather than maintenance, which matters because chronic, low-grade brain inflammation is one of the most consistent biological signatures found in Alzheimer’s tissue examined after death.

Why age outranks every other Alzheimer’s risk factor

Age has long topped every list of Alzheimer’s risk factors, ahead of genetics, cardiovascular health or lifestyle. The National Institute on Aging states plainly that “age is the biggest known risk factor for Alzheimer’s”, but the biological mechanism behind that statistical fact has remained largely unexplained. Most Alzheimer’s research has instead focused on the amyloid plaques and tau tangles that accumulate later in the disease.

The hippocampus findings suggest a mechanism that predates those hallmark changes by years or decades. If the brain’s immune housekeeping crew is quietly being swapped out for a less effective, more inflammatory workforce starting in a person’s 50s, that shift could set the stage for the neurodegeneration that becomes visible only much later.

Nathan Zemke, director of single-cell genomics at the University of California San Diego’s Center for Epigenomics and a co-author on the paper, called the work “a major step forward in understanding how aging reshapes the human genome in brain cells,” a framing that positions the microglia turnover as one piece of a broader genomic reorganization rather than an isolated glitch.

Inside the single-cell atlas behind the discovery

The paper, titled “Epigenetic and 3D genome reprogramming during the aging of the human hippocampus,” grew out of the National Institutes of Health’s 4D Nucleome program, a decade-long federal effort, running from 2015 to 2025, to map how the genome’s physical folding and organization change across cell types and life stages. Hippocampus tissue donated for research gave the team a rare opportunity to profile aging in a brain region directly implicated in memory loss, rather than relying on blood samples or animal proxies.

Using single-cell sequencing, the researchers were able to separate out individual cell populations within hippocampal tissue and track how their gene regulation, not just their gene expression, shifted with age. That distinction matters: epigenetic reprogramming, the addition or removal of chemical tags that turn genes on or off, can precede visible changes in cell behavior by years.

Xiangmin Xu, a professor at the University of California Irvine who directs its Center for Neural Circuit Mapping, said the results point to something broader than any single cell type. Aging in the hippocampus, he noted, “involves coordinated and dynamic remodeling of immune, vascular, and neuronal systems,” a description echoed in the National Institutes of Health’s own summary of the study, which helped fund the underlying genome-mapping program.

The unanswered questions the study leaves open

The paper does not establish that the microglia turnover causes Alzheimer’s, only that it coincides with the decades in which the disease’s risk climbs steepest. Whether slowing or reversing the cell handoff would change a person’s actual disease trajectory is untested.

ScienceDaily’s write-up of the release frames the hippocampus atlas as one of the most detailed pictures yet of how genome regulation shifts with age, but detail is not the same as proof of cause. That gap is exactly where the next phase of research is aimed.

The 50-to-75 window itself is also still coarse. The researchers have not yet pinned down whether the shift happens gradually across those 25 years or arrives closer to a single tipping point, a distinction that would matter enormously for any future effort to intervene before symptoms appear.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

More from Morning Overview